Rocket Pharmaceuticals Inc
RCKT
Market Cap$312.44M
Close$
$1.46
49.8% downside
Current Fair Value
49.8% downsideOvervalued by 49.8% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $312.44 Million |
|---|---|
| Enterprise Value | $287.98 Million |
| Dividend Yield | $0 (0%) |
| Earnings per Share | $-2.73 |
| Beta | 0.68 |
| Outstanding Shares | 110,093,461 |
Return
| Return on Equity | - |
|---|---|
| Return on Assets | - |
| Return on Invested Capital | - |
Valuation & Multiples
| P/E Ratio | -1.24 |
|---|---|
| PEG | 106.64 |
| Price to Sales | - |
| Price to Book Ratio | 0.97 |
| Enterprise Value to Revenue | - |
| Enterprise Value to EBIT | -1.09 |
| Enterprise Value to Net Income | -2 |
| Total Debt to Enterprise | 0.09 |
| Debt to Equity | 0.06 |
Revenue Sources
No data
Insider Trades
ESG Score
No data
About Rocket Pharmaceuticals Inc
151 employees
CEO: Gaurav Shah